Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5003
Source ID: NCT03350984
Associated Drug: Nph Insulin
Title: Insulin Schemes for Type 2 Diabetes Control
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT03350984/results
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: NPH insulin|DRUG: Glargine and Lispro insulin
Outcome Measures: Primary: Differences in the Mean Daily Blood Glucose Between a Basal-bolus Scheme and NPH Schemes of Insulin., To determine the differences in the mean daily blood glucose measured in mg/dl, between a basal-bolus scheme and NPH schemes of insulin measured by the mean daily blood glucose., Fasting blood glucose was taken every day, before breakfast, up to 4 weeks; postprandial glucose was taken every day, 2 hours after breakfast, 2 hours after lunch, and 2 hours after dinner, up to 4 weeks; glucose early morning was taken 3 am, up to 4 week | Secondary: the Number of Participants With Mild and Severe Hypoglycemic Events, To measure the number of participants with mild and severe hypoglycemic events, Duration of hospital stay, up to 4 weeks.|Number of Participants With Sustained Glycemic Control During Hospital Stay, Sustained glycemic control were the number of participants who not had: discharged before sustained control, critical status suspension, death before control, bad attachment to the protocol, interruption due to more than 2 hypoglycemic events during their hospital stay., blood glucose was taken every day, up to 4 weeks.
Sponsor/Collaborators: Sponsor: Universidad de Guanajuato
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 75
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2017-11-02
Completion Date: 2018-07-01
Results First Posted: 2020-01-18
Last Update Posted: 2021-12-06
Locations: Hospital General de León, León, Guanajuato, 37680, Mexico
URL: https://clinicaltrials.gov/show/NCT03350984